Trial Profile
Phase II trial of flavopiridol [alvocidib] and paclitaxel in patients with paclitaxel-refractory esophageal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Alvocidib (Primary) ; Paclitaxel
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 06 Aug 2007 Status changed from suspended to completed.
- 16 Sep 2005 New trial record.